What it's for (Indications)
- Polymyxin B and zinc bacitracin combination is primarily indicated for the topical treatment of susceptible superficial bacterial infections affecting the external structures of the eye.
- These ophthalmic infections commonly include bacterial conjunctivitis, blepharitis, and superficial keratitis or corneal ulcers caused by organisms sensitive to one or both of the active components.
- Polymyxin B demonstrates potent bactericidal activity against a wide range of Gram-negative bacteria, including prevalent ocular pathogens such as *Pseudomonas aeruginosa*, *Escherichia coli*, *Klebsiella* species, and *Enterobacter* species.
- Zinc bacitracin concurrently provides effective coverage against Gram-positive bacteria, encompassing clinically significant strains like *Staphylococcus aureus* (including some methicillin-resistant strains), *Streptococcus pyogenes*, and other *Streptococcus* species.
- The synergistic action of these two antibiotics significantly broadens the antimicrobial spectrum, offering comprehensive empiric coverage against the most frequently encountered bacterial pathogens responsible for ocular infections.
- This combination is typically reserved for localized external infections where broad-spectrum antibacterial activity is clinically warranted to prevent the progression of infection and alleviate associated symptoms such as inflammation, purulent discharge, and discomfort.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | Apply as directed by a physician, typically up to six times a day. For consistent application, it is recommended to apply at the same time each day. If a dose is missed, apply it as soon as remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped. Treatment can be stopped immediately upon completion of the prescribed duration without tapering. |
Safety & Warnings
Common Side Effects
- Temporary blurry vision may occur after application.
- For specific concerns during pregnancy or lactation, patients should consult their physician regarding risks and benefits or case-specific recommendations.
- Alcohol consumption may exacerbate potential side effects.
Serious Warnings
- Black Box Warning: None
- Do not drive immediately after applying due to potential blurry vision; similarly, application before going out in the sun is not recommended for the same reason.
- Avoid contact of the ointment with the mouth or nose.
- Contact lenses should not be worn while using this medication.
- Excessive use is to be avoided, and the medication should not be used for longer than prescribed by a doctor.
- Alcohol consumption should be limited as it may worsen side effects.
- There are no known effects on liver or kidney function.
How it Works (Mechanism of Action)
The therapeutic efficacy of the polymyxin B and zinc bacitracin combination stems from their distinct yet complementary mechanisms of action, which collectively target crucial bacterial structures and physiological processes. Polymyxin B, a cyclic polypeptide antibiotic, exerts its potent bactericidal effect primarily by disrupting the integrity of the bacterial cell membrane, particularly in Gram-negative organisms. It acts as a cationic detergent, binding avidly to the negatively charged lipopolysaccharide (LPS) components in the outer membrane of Gram-negative bacteria. This binding mechanism displaces essential divalent cations, such as magnesium and calcium, which are critical for maintaining membrane stability, leading to increased permeability. Subsequently, polymyxin B directly damages the underlying cytoplasmic membrane, resulting in the leakage of vital intracellular contents like nucleotides, proteins, and ions, ultimately causing rapid bacterial cell death. Zinc bacitracin, another polypeptide antibiotic, interferes with the essential process of bacterial cell wall synthesis. Specifically, it inhibits the dephosphorylation of C55-isoprenyl pyrophosphate (also known as undecaprenyl pyrophosphate), a critical lipid carrier molecule. This lipid carrier is indispensable for transporting peptidoglycan precursors across the bacterial cell membrane, where they are incorporated into the nascent cell wall. By blocking the regeneration of this lipid carrier, bacitracin effectively prevents the proper formation of the peptidoglycan layer, leading to a structurally defective and osmotically fragile cell wall. This compromised cell wall integrity ultimately results in bacterial cell lysis and death. The inclusion of zinc enhances the stability and antimicrobial potency of bacitracin. The co-administration of polymyxin B and zinc bacitracin provides a comprehensive spectrum of activity against both Gram-negative and Gram-positive bacteria, minimizing the potential for monotherapy-associated resistance and enhancing overall therapeutic outcomes against susceptible bacterial infections.
Commercial Brands (Alternatives)
No other brands found for this formula.